Alcon (United Kingdom)

Alcon (United Kingdom)

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alcon (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

44%


Total
Publications

159


Total Open
Publications

70


Total
Citations

4.7K


Open Access
Percentage

44%


Total
Publications

159


Total Open
Publications

70


Total
Citations

4.7K

Wikipedia

Website

download

Breakdown

24% 9% 11% 56%

Publisher Open

24%

Both

9%

Other Platform Open

11%

Closed

56%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0123456789101112Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

13%OA Journal

OA Journal 13%

7

Hybrid 47%

25

No Guarantees 40%

21

Other Platform Open

Domain 58%

18

Institution 42%

13

Public 13%

4

Preprint 6%

2

Other Internet 6%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
18
University College London - UCL Discovery
Institution
8
King's College London - Research Portal
Institution
7
Europe PMC
Domain
6
University of Strathclyde - Strathprints: The University of Strathclyde institutional repository
Institution
3
Semantic Scholar
Public
3
University of Edinburgh - Edinburgh Research Explorer
Institution
2
University of Birmingham - University of Birmingham Research Portal
Institution
2
Newcastle Univesity - Newcastle University ePrints
Institution
2
bioRxiv
Preprint
2
1 / 2

Data updated 7 April 2025

Share

Share

Share